Portfolio

New Drug R&D

  
ANYA BIOPHARM INC.
ANYA BIOPHARM INC. utilizing the MIRA/JE® patent platform to overcome challenges in oral peptide drug delivery.

New Drug R&D

  
Onward Therapeutics
Onward therapeutics is a development stage oncology company, focusing on bi-specific antibody and allogenic NK-cell therapy.

New Drug R&D

  
Immunwork
Immunwork focuses on the R&D of a class of new drugs, which are created based on our proprietary “T-E pharmaceuticals” technology platform.

New Drug R&D

  
AiViva BioPharma
AiVivia's JEL™ delivery method directly targets local disorders with minimal systemic exposure, a basis for a favorable benefit-risk profile.

New Drug R&D

  

Core Business

  
Lumosa Therapeutics
Lumosa is a clinical-stage pharmaceutical company dedicated to the development of novel solutions for neurological and oncological diseases.

New Drug R&D

  

Core Business

  
Shanghai Bao Pharmaceuticals
Bao Pharmaceuticals focuses on the development and commercialization of recombinant protein drugs and antibody drugs.

New Drug R&D

  
Jacobio Pharmaceuticals
Jacobio is a biopharmaceutical company that develops innovative drugs. It targets undruggable proteins with allosteric mechanisms and molecules.